Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	GTF2A1 NCOA6 TOB2 ARNT MED12L TFDP3 TACC2 RUNX1 TRIM24 NFAT5 DCP1A	1.60e-06	753	49	11	GO:0008134
GeneOntologyMolecularFunction	transcription coregulator activity	MED15 KMT2C NCOA6 TOB2 MED12L DYRK1A WWTR1 TRIM24	6.11e-05	562	49	8	GO:0003712
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	GTF2A1 NCOA6 TOB2 ARNT TFDP3 TACC2 TRIM24	6.64e-05	417	49	7	GO:0061629
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	GTF2A1 NCOA6 TOB2 ARNT TFDP3 TACC2 RUNX1 TRIM24	7.80e-05	582	49	8	GO:0140297
GeneOntologyMolecularFunction	transcription coactivator activity	KMT2C NCOA6 MED12L DYRK1A WWTR1 TRIM24	9.39e-05	303	49	6	GO:0003713
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX6 GTF2A1 ARNT LMX1B TFDP3 CC2D1A CHD7 RUNX1 TRIM24 MGA NFAT5 RFX2	1.61e-04	1459	49	12	GO:0000977
GeneOntologyMolecularFunction	molecular adaptor activity	MED15 KMT2C NCOA6 TOB2 IGF2BP1 NELFA MED12L DYRK1A OTUD4 WWTR1 TRIM24	3.60e-04	1356	49	11	GO:0060090
GeneOntologyMolecularFunction	co-SMAD binding	TRIM33 USP9X	3.83e-04	12	49	2	GO:0070410
GeneOntologyMolecularFunction	chromatin binding	TRIM33 NCOA6 TOX4 NELFA CHD7 RUNX1 TRIM24 NFAT5	3.98e-04	739	49	8	GO:0003682
GeneOntologyMolecularFunction	protein dimerization activity	SOX6 AMELY GTF2A1 ARNT NOD1 SRM WWTR1 ODC1 RUNX1 MGA	5.85e-04	1205	49	10	GO:0046983
GeneOntologyMolecularFunction	K63-linked deubiquitinase activity	USP9X OTUD4	6.93e-04	16	49	2	GO:0061578
GeneOntologyMolecularFunction	protein homodimerization activity	SOX6 AMELY ARNT NOD1 SRM WWTR1 ODC1 RUNX1	7.60e-04	815	49	8	GO:0042803
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 TOB2	8.80e-04	18	49	2	GO:0042809
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX6 ARNT TFDP3 CC2D1A CHD7 RUNX1 TRIM24 MGA NFAT5 RFX2	8.85e-04	1271	49	10	GO:0000987
GeneOntologyMolecularFunction	promoter-specific chromatin binding	TRIM33 CHD7 RUNX1	1.11e-03	83	49	3	GO:1990841
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA6 TOB2 TACC2 TRIM24	1.14e-03	187	49	4	GO:0016922
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MED15 KMT2C NCOA6 TOB2 IGF2BP1 MED12L DYRK1A WWTR1 TRIM24	1.83e-03	1160	49	9	GO:0030674
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX6 ARNT CC2D1A CHD7 RUNX1 TRIM24 MGA NFAT5 RFX2	2.94e-03	1244	49	9	GO:0000978
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	SOX6 MED15 TET2 KMT2C GTF2A1 NCOA6 ARNT LMX1B NELFA CAPRIN2 MED12L TFDP3 WWTR1 CHD7 POGZ RUNX1 MGA NFAT5 RFX2	1.99e-10	1390	50	19	GO:0045944
GeneOntologyCellularComponent	transcription regulator complex	SOX6 MED15 GTF2A1 NCOA6 ARNT TFDP3 WWTR1 RUNX1 MGA NFAT5 DCP1A	1.26e-07	596	50	11	GO:0005667
GeneOntologyCellularComponent	chromatin	SOX6 TRIM33 EXOSC10 ARNT TOX4 LMX1B TFDP3 CHD7 POGZ RUNX1 TRIM24 MGA NFAT5 RFX2	6.23e-06	1480	50	14	GO:0000785
GeneOntologyCellularComponent	nuclear protein-containing complex	MED15 KMT2C GTF2A1 NCOA6 EXOSC10 ARNT TINF2 NELFA MED12L TFDP3 RUNX1 MGA	7.41e-05	1377	50	12	GO:0140513
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C NCOA6	3.64e-04	12	50	2	GO:0044666
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	MED15 GTF2A1 ARNT TFDP3 RUNX1	4.72e-04	272	50	5	GO:0090575
GeneOntologyCellularComponent	histone methyltransferase complex	KMT2C NCOA6 MGA	7.70e-04	75	50	3	GO:0035097
HumanPheno	Juvenile aseptic necrosis	FN1 TINF2 LMX1B DYRK1A	1.93e-05	43	20	4	HP:0100323
HumanPheno	Sacrococcygeal pilonidal abnormality	NELFA USP9X RTTN DYRK1A ODC1	6.09e-05	114	20	5	HP:0010767
HumanPheno	Abnormal finger morphology	SOX6 TET2 KMT2C FN1 TINF2 LMX1B NELFA USP9X RTTN MED12L DYRK1A CHD7 POGZ ODC1	7.87e-05	1385	20	14	HP:0001167
HumanPheno	Long fingers	SOX6 KMT2C NELFA USP9X MED12L DYRK1A ODC1	1.04e-04	306	20	7	HP:0100807
HumanPheno	Reduced impulse control	SOX6 TET2 KMT2C USP9X RTTN MED12L DYRK1A CC2D1A CHD7 POGZ ODC1 RUNX1	1.12e-04	1032	20	12	HP:5200045
HumanPheno	Abnormality of the palpebral fissures	SOX6 KMT2C LMX1B NELFA USP9X RTTN MED12L DYRK1A CHD7 POGZ ODC1	1.42e-04	880	20	11	HP:0008050
HumanPheno	Narrow mouth	SOX6 LMX1B RTTN MED12L CHD7 POGZ	1.98e-04	234	20	6	HP:0000160
HumanPheno	Increased proportion of CD25+ mast cells	TET2 RUNX1	2.18e-04	6	20	2	HP:0031408
HumanPheno	Abnormal serum mast cell beta-tryptase concentration	TET2 RUNX1	2.18e-04	6	20	2	HP:0031900
HumanPheno	Elevated total serum tryptase	TET2 RUNX1	2.18e-04	6	20	2	HP:0031901
HumanPheno	Abnormal thorax morphology	SOX6 TET2 KMT2C FN1 LMX1B NELFA RTTN MED12L DYRK1A CHD7 POGZ ODC1 DYSF	2.81e-04	1328	20	13	HP:0000765
HumanPheno	Intellectual disability, severe	LMX1B SOBP NELFA RTTN DYRK1A CC2D1A POGZ	3.47e-04	371	20	7	HP:0010864
HumanPheno	Abnormal sacrum morphology	NELFA USP9X RTTN DYRK1A ODC1	3.71e-04	167	20	5	HP:0005107
HumanPheno	Disinhibition	SOX6 KMT2C USP9X RTTN MED12L DYRK1A CC2D1A CHD7 POGZ ODC1	3.81e-04	807	20	10	HP:0000734
HumanPheno	Inappropriate behavior	SOX6 KMT2C USP9X RTTN MED12L DYRK1A CC2D1A CHD7 POGZ ODC1	3.81e-04	807	20	10	HP:0000719
HumanPheno	Abnormal response to social norms	SOX6 KMT2C USP9X RTTN MED12L DYRK1A CC2D1A CHD7 POGZ ODC1	3.81e-04	807	20	10	HP:5200123
HumanPheno	Social disinhibition	SOX6 KMT2C USP9X RTTN MED12L DYRK1A CC2D1A CHD7 POGZ ODC1	3.81e-04	807	20	10	HP:5200029
HumanPheno	Avascular necrosis	FN1 TINF2 LMX1B DYRK1A	3.87e-04	92	20	4	HP:0010885
HumanPheno	Abnormal basophil morphology	TET2 RUNX1	4.04e-04	8	20	2	HP:0001912
HumanPheno	Anaphylactic shock	TET2 RUNX1	4.04e-04	8	20	2	HP:0100845
HumanPheno	Abnormal mast cell morphology	TET2 RUNX1	4.04e-04	8	20	2	HP:0100494
HumanPheno	Abdominal cramps	TET2 RUNX1	4.04e-04	8	20	2	HP:0032155
HumanPheno	Aggressive behavior	KMT2C USP9X RTTN MED12L DYRK1A CHD7 POGZ ODC1	4.39e-04	516	20	8	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	KMT2C USP9X RTTN MED12L DYRK1A CHD7 POGZ ODC1	4.39e-04	516	20	8	HP:0006919
HumanPheno	Budd-Chiari syndrome	TET2 TINF2	5.19e-04	9	20	2	HP:0002639
HumanPheno	Iris coloboma	NELFA MED12L DYRK1A CHD7 POGZ	5.66e-04	183	20	5	HP:0000612
HumanPheno	Hypermetropia	KMT2C SOBP USP9X MED12L DYRK1A POGZ	6.12e-04	288	20	6	HP:0000540
HumanPheno	Abnormal soft palate morphology	SOX6 KMT2C USP9X DYRK1A CHD7 POGZ	6.23e-04	289	20	6	HP:0100736
HumanPheno	Duodenal atresia	RTTN DYRK1A CHD7	6.61e-04	45	20	3	HP:0002247
HumanPheno	Abnormal midface morphology	KMT2C FN1 TINF2 LMX1B SOBP NELFA CHD7 POGZ ODC1	7.05e-04	704	20	9	HP:0000309
HumanPheno	Abnormally increased volition	SOX6 KMT2C USP9X RTTN MED12L DYRK1A CC2D1A CHD7 POGZ ODC1	7.05e-04	869	20	10	HP:5200263
HumanPheno	Sacral dimple	NELFA USP9X DYRK1A ODC1	7.64e-04	110	20	4	HP:0000960
HumanPheno	Broad chin	LMX1B DYRK1A	7.89e-04	11	20	2	HP:0011822
MousePheno	small tectum	LMX1B DYRK1A	9.68e-06	2	44	2	MP:0006105
MousePheno	lethality during fetal growth through weaning, incomplete penetrance	SOX6 TET2 GTF2A1 NCOA6 IGF2BP1 LMX1B DYRK1A CC2D1A WWTR1 CHD7 POGZ RUNX1 NFAT5	2.69e-05	1124	44	13	MP:0011112
MousePheno	prenatal growth retardation	TRIM33 NCOA6 IGF2BP1 ARNT TOX4 FN1 RTTN DYRK1A TFDP3 CHD7 DCP1A	5.79e-05	869	44	11	MP:0010865
MousePheno	embryonic growth retardation	TRIM33 NCOA6 ARNT TOX4 FN1 RTTN DYRK1A TFDP3 CHD7 DCP1A	1.01e-04	763	44	10	MP:0003984
MousePheno	decreased superior colliculus size	LMX1B DYRK1A	1.44e-04	6	44	2	MP:0002892
MousePheno	perinatal lethality, incomplete penetrance	SOX6 TET2 GTF2A1 NCOA6 IGF2BP1 LMX1B CC2D1A WWTR1	1.50e-04	503	44	8	MP:0011090
MousePheno	myeloid hyperplasia	TET2 TINF2 RUNX1	1.63e-04	34	44	3	MP:0010373
MousePheno	decreased embryo size	TRIM33 NCOA6 ARNT FN1 USP9X RTTN DYRK1A TFDP3 DCP1A	1.75e-04	659	44	9	MP:0001698
MousePheno	abnormal embryo development	TRIM33 NCOA6 EXOSC10 ARNT TOX4 FN1 LMX1B USP9X RTTN DYRK1A TFDP3 CHD7 DCP1A	2.07e-04	1370	44	13	MP:0001672
MousePheno	abnormal parietal lobe morphology	DYRK1A CHD7 POGZ	2.10e-04	37	44	3	MP:0000794
MousePheno	embryonic lethality during organogenesis	NCOA6 ARNT FN1 RTTN DYRK1A TFDP3 CHD7 POGZ RUNX1 DCP1A	3.12e-04	876	44	10	MP:0006207
MousePheno	abnormal trophoblast giant cell morphology	NCOA6 ARNT TFDP3 MGA	3.36e-04	106	44	4	MP:0005033
MousePheno	abnormal mural trophectoderm morphology	NCOA6 ARNT TFDP3 MGA	3.48e-04	107	44	4	MP:0012057
MousePheno	anemia	TET2 IGF2BP1 FN1 POGZ RUNX1 NFAT5	3.67e-04	306	44	6	MP:0001577
MousePheno	prenatal lethality, incomplete penetrance	KMT2C NCOA6 ARNT FN1 GOLGA6C DYRK1A WWTR1 CHD7 POGZ	4.44e-04	747	44	9	MP:0011101
MousePheno	abnormal fetal cardiomyocyte proliferation	NCOA6 CHD7 NFAT5	4.56e-04	48	44	3	MP:0003567
MousePheno	abnormal prenatal growth/weight/body size	TRIM33 NCOA6 IGF2BP1 ARNT TOX4 FN1 USP9X RTTN DYRK1A TFDP3 CHD7 POGZ DCP1A	4.84e-04	1493	44	13	MP:0004196
Domain	HMG_box	SOX6 KMT2C TOX4	3.62e-04	53	49	3	PF00505
Domain	p53-like_TF_DNA-bd	RUNX1 MGA NFAT5	3.62e-04	53	49	3	IPR008967
Domain	HMG	SOX6 KMT2C TOX4	3.83e-04	54	49	3	SM00398
Domain	HMG_box_dom	SOX6 KMT2C TOX4	6.61e-04	65	49	3	IPR009071
Domain	Bbox_C	TRIM33 TRIM24	6.93e-04	15	49	2	IPR003649
Domain	BBC	TRIM33 TRIM24	6.93e-04	15	49	2	SM00502
Domain	PHD	TRIM33 KMT2C TRIM24	1.00e-03	75	49	3	PF00628
Domain	Znf_PHD-finger	TRIM33 KMT2C TRIM24	1.17e-03	79	49	3	IPR019787
Domain	PHD	TRIM33 KMT2C TRIM24	1.64e-03	89	49	3	SM00249
Domain	Znf_PHD	TRIM33 KMT2C TRIM24	1.75e-03	91	49	3	IPR001965
Domain	ZF_PHD_2	TRIM33 KMT2C TRIM24	1.98e-03	95	49	3	PS50016
Domain	ZF_PHD_1	TRIM33 KMT2C TRIM24	2.04e-03	96	49	3	PS01359
Domain	BROMODOMAIN_1	TRIM33 TRIM24	4.24e-03	37	49	2	PS00633
Domain	Bromodomain	TRIM33 TRIM24	4.46e-03	38	49	2	PF00439
Domain	BROMODOMAIN_2	TRIM33 TRIM24	5.18e-03	41	49	2	PS50014
Domain	BROMO	TRIM33 TRIM24	5.43e-03	42	49	2	SM00297
Domain	Bromodomain	TRIM33 TRIM24	5.43e-03	42	49	2	IPR001487
Domain	-	TRIM33 TRIM24	5.43e-03	42	49	2	1.20.920.10
Domain	Znf_FYVE_PHD	TRIM33 KMT2C TRIM24	6.75e-03	147	49	3	IPR011011
Pathway	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	TRIM33 USP9X WWTR1	7.11e-05	31	37	3	M669
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	USP9X TFDP3 WWTR1	1.66e-04	41	37	3	MM14876
Pubmed	Human transcription factor protein interaction networks.	SOX6 MED15 TET2 TRIM33 KMT2C NCOA6 IGF2BP1 ARNT SOBP USP9X OTUD4 CC2D1A R3HDM2 CHD7 POGZ TRIM24 MGA DCP1A	5.18e-13	1429	50	18	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	MED15 TET2 TRIM33 KMT2C NCOA6 ARNT SOBP CHD7 POGZ TRIM24 MGA	2.49e-12	351	50	11	38297188
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MED15 TET2 TRIM33 KMT2C NCOA6 EXOSC10 IGF2BP1 ARNT NELFA SRM CC2D1A CHD7 POGZ RUNX1 TRIM24	2.39e-11	1103	50	15	34189442
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MED15 TET2 TRIM33 NCOA6 EXOSC10 NELFA CHD7 TRIM24 MGA	1.59e-10	268	50	9	33640491
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MED15 KMT2C NCOA6 EXOSC10 TOX4 USP9X CC2D1A WWTR1 POGZ MGA DCP1A	2.94e-10	549	50	11	38280479
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	TRIM33 GTF2A1 EXOSC10 TOX4 NELFA TFDP3 POGZ TRIM24 MGA	1.26e-09	339	50	9	30415952
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	MED15 TET2 TRIM33 KMT2C DYRK1A CHD7 POGZ TRIM24 MGA	5.09e-09	398	50	9	35016035
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	KMT2C NCOA6 EXOSC10 YIPF5 ARNT TOX4 TINF2 WWTR1 CHD7 POGZ SLFN5 RUNX1 MGA	2.43e-08	1294	50	13	30804502
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	MED15 TET2 GTF2A1 ARNT SOBP R3HDM2	8.56e-08	152	50	6	38360978
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	ARNT LMX1B DYRK1A OTUD4 CHD7 POGZ RUNX1 MGA NFAT5	1.34e-07	583	50	9	29844126
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 TOX4 TFDP3 CHD7 POGZ TRIM24 MGA DCP1A	1.41e-07	418	50	8	34709266
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED15 TRIM33 KMT2C USP9X POGZ MGA	1.49e-07	167	50	6	20362541
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX6 GTF2A1 ARNT TOX4 TFDP3 POGZ TRIM24 MGA NFAT5 RFX2	1.92e-07	808	50	10	20412781
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MED15 TRIM33 ARNT NELFA TACC2 TRIM24 MGA DCP1A	2.22e-07	444	50	8	34795231
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KMT2C GTF2A1 ARNT TOX4 TFDP3 TACC2 POGZ NFAT5 DCP1A	6.87e-07	709	50	9	22988430
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	TRIM33 EXOSC10 TOX4 DYRK1A POGZ TRIM24 MGA	7.74e-07	357	50	7	37059091
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	KMT2C NCOA6 TOX4 TINF2 POGZ	8.07e-07	119	50	5	23508102
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TRIM33 NCOA6 EXOSC10 IGF2BP1 TOX4 TINF2 CHD7 POGZ TRIM24 MGA	8.74e-07	954	50	10	36373674
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	TRIM33 CHD7 POGZ TRIM24 MGA	1.03e-06	125	50	5	32891193
Pubmed	Trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells.	TRIM33 TRIM24	2.03e-06	2	50	2	32932986
Pubmed	Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the Coiled-Coil motif.	TRIM33 TRIM24	2.03e-06	2	50	2	22123502
Pubmed	T-cell receptor signaling induces proximal Runx1 transactivation via a calcineurin-NFAT pathway.	RUNX1 NFAT5	2.03e-06	2	50	2	24310293
Pubmed	TAZ suppresses NFAT5 activity through tyrosine phosphorylation.	WWTR1 NFAT5	2.03e-06	2	50	2	23045390
Pubmed	Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.	TET2 KMT2C	2.03e-06	2	50	2	26880370
Pubmed	Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.	TET2 RUNX1	2.03e-06	2	50	2	27997762
Pubmed	Silencing of IGF2BP1 restrains ox-LDL-induced lipid accumulation and inflammation by reducing RUNX1 expression and promoting autophagy in macrophages.	IGF2BP1 RUNX1	2.03e-06	2	50	2	35179253
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KMT2C EXOSC10 FN1 DYRK1A OTUD4 TACC2 CHD7 MGA NFAT5 DCP1A	2.75e-06	1084	50	10	11544199
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SOX6 TRIM33 USP9X CHD7 SLFN5 RUNX1	3.17e-06	282	50	6	23667531
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	GTF2A1 NCOA6 EXOSC10 TOX4 CHD7 MGA	3.24e-06	283	50	6	30585729
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TRIM33 ARNT DYRK1A WWTR1 POGZ TRIM24 MGA RFX2 DCP1A	3.25e-06	857	50	9	25609649
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MED15 TRIM33 KMT2C NCOA6 ARNT WWTR1 TRIM24	3.96e-06	457	50	7	32344865
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX6 ARNT TOX4 LMX1B TFDP3 RUNX1 MGA NFAT5 RFX2	5.20e-06	908	50	9	19274049
Pubmed	RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.	IGF2BP1 RUNX1	6.07e-06	3	50	2	37670323
Pubmed	The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.	TRIM33 TRIM24	6.07e-06	3	50	2	10439047
Pubmed	Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression.	TRIM33 TRIM24	6.07e-06	3	50	2	12096914
Pubmed	Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains.	TRIM33 TRIM24	6.07e-06	3	50	2	36098557
Pubmed	RUNX1 regulates SMAD1 by transcriptionally activating the expression of USP9X, regulating the activation of hepatic stellate cells and liver fibrosis.	USP9X RUNX1	6.07e-06	3	50	2	33933467
Pubmed	Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design.	TRIM33 TRIM24	6.07e-06	3	50	2	36430693
Pubmed	Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.	KMT2C NCOA6	6.07e-06	3	50	2	18372346
Pubmed	Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.	KMT2C NCOA6	6.07e-06	3	50	2	21330447
Pubmed	IGF2BP1 expression in human mesenchymal stem cells significantly affects their proliferation and is under the epigenetic control of TET1/2 demethylases.	TET2 IGF2BP1	6.07e-06	3	50	2	24915579
Pubmed	ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.	IGF2BP1 RUNX1	6.07e-06	3	50	2	26852652
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 CHD7 POGZ TRIM24	6.39e-06	83	50	4	28794006
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	GTF2A1 TOX4 TINF2 USP9X CHD7	9.55e-06	197	50	5	20811636
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 TRIM33 KMT2C NCOA6 CAPRIN2 MED12L POGZ	1.03e-05	529	50	7	14621295
Pubmed	KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.	TRIM33 TRIM24	1.21e-05	4	50	2	34392614
Pubmed	Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.	TET2 RUNX1	1.21e-05	4	50	2	23065512
Pubmed	TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage.	TRIM33 TRIM24	1.21e-05	4	50	2	24820418
Pubmed	Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.	TRIM33 TRIM24	1.21e-05	4	50	2	21531907
Pubmed	Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.	IGF2BP1 WWTR1	1.21e-05	4	50	2	36308276
Pubmed	Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.	TET2 RUNX1	1.21e-05	4	50	2	32341038
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TRIM33 TOB2 IGF2BP1 USP9X DYRK1A OTUD4 CC2D1A POGZ DCP1A	1.51e-05	1038	50	9	26673895
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	TRIM33 NELFA POGZ TRIM24 MGA	1.70e-05	222	50	5	37071664
Pubmed	TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding.	AMELY FN1	2.02e-05	5	50	2	17699513
Pubmed	Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.	TRIM33 USP9X	2.02e-05	5	50	2	28115363
Pubmed	HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells.	ARNT USP9X	2.02e-05	5	50	2	34592152
Pubmed	TIF1gamma, a novel member of the transcriptional intermediary factor 1 family.	TRIM33 TRIM24	2.02e-05	5	50	2	10022127
Pubmed	TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal.	MED15 WWTR1	2.02e-05	5	50	2	18568018
Pubmed	Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase.	USP9X OTUD4 MGA	2.46e-05	39	50	3	25944111
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TOB2 OTUD4 R3HDM2 LRRC7 POGZ NFAT5	2.55e-05	407	50	6	12693553
Pubmed	FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.	TRIM33 USP9X	3.03e-05	6	50	2	19135894
Pubmed	CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation.	CHD7 RUNX1	3.03e-05	6	50	2	32883883
Pubmed	TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.	WWTR1 RUNX1	3.03e-05	6	50	2	11118213
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	KMT2C NCOA6	3.03e-05	6	50	2	17021013
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SOX6 GTF2A1 ARNT LMX1B NELFA WWTR1 TRIM24 RFX2	3.33e-05	877	50	8	20211142
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	TRIM33 NELFA TRIM24 MGA	4.23e-05	134	50	4	25452129
Pubmed	A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.	KMT2C NCOA6	4.23e-05	7	50	2	19433796
Pubmed	Runx1 and Runx2 cooperate during sternal morphogenesis.	SOX6 RUNX1	4.23e-05	7	50	2	20181744
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	KMT2C NCOA6	4.23e-05	7	50	2	19556342
Pubmed	Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.	MED15 KMT2C NCOA6	4.62e-05	48	50	3	27703004
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	KMT2C CHD7 POGZ MGA	5.91e-05	146	50	4	23892456
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	EXOSC10 FN1 USP9X OTUD4 NFAT5 DCP1A	6.01e-05	475	50	6	31040226
Pubmed	Csf2 null mutation alters placental gene expression and trophoblast glycogen cell and giant cell abundance in mice.	NCOA6 ARNT TFDP3	6.59e-05	54	50	3	19228596
Pubmed	A human MAP kinase interactome.	KMT2C GTF2A1 TOX4 WWTR1 POGZ MGA	6.82e-05	486	50	6	20936779
Pubmed	TBR1 regulates autism risk genes in the developing neocortex.	DYRK1A POGZ	7.25e-05	9	50	2	27325115
Pubmed	Mga is essential for the survival of pluripotent cells during peri-implantation development.	ODC1 MGA	7.25e-05	9	50	2	25516968
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	IGF2BP1 NELFA USP9X OTUD4 CC2D1A TACC2	8.23e-05	503	50	6	16964243
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	KMT2C NCOA6 TRIM24	8.59e-05	59	50	3	28813667
Pubmed	A fibronectin gradient remodels mixed-phase mesoderm.	FN1 WWTR1	9.05e-05	10	50	2	39028807
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KMT2C ARNT NOD1 TINF2 NELFA USP9X DYRK1A SRM MGA	1.02e-04	1327	50	9	32694731
Pubmed	Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.	YIPF5 USP9X DYRK1A OTUD4 CC2D1A	1.07e-04	327	50	5	15592455
Pubmed	Functional consequences of necdin nucleocytoplasmic localization.	SOBP WWTR1 POGZ	1.10e-04	64	50	3	22442722
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA6 NELFA OTUD4 CHD7 POGZ RUNX1 DCP1A	1.14e-04	774	50	7	15302935
Pubmed	PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells.	MED15 NCOA6 MGA	1.15e-04	65	50	3	22496869
Pubmed	Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.	MED15 TRIM33 ARNT	1.20e-04	66	50	3	23275444
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	TRIM33 USP9X TRIM24 DCP1A	1.30e-04	179	50	4	36261009
Pubmed	Loss of Usp9x disrupts cortical architecture, hippocampal development and TGFβ-mediated axonogenesis.	USP9X RUNX1	1.32e-04	12	50	2	23861879
Pubmed	Kindlin-2 Is Essential for Preserving Integrity of the Developing Heart and Preventing Ventricular Rupture.	FN1 WWTR1	1.32e-04	12	50	2	30883226
Pubmed	TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.	TRIM33 TRIM24	1.32e-04	12	50	2	30479348
Pubmed	Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.	TET2 RUNX1	1.32e-04	12	50	2	20678218
Pubmed	Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners.	DYRK1A RUNX1	1.32e-04	12	50	2	27100087
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	TET2 EXOSC10 IGF2BP1 USP9X OTUD4 MGA	1.35e-04	551	50	6	34728620
Pubmed	ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.	TET2 RUNX1	1.56e-04	13	50	2	20880116
Pubmed	Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.	KMT2C NCOA6	1.56e-04	13	50	2	17761849
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KMT2C NCOA6 LMX1B RTTN SNX8 DYRK1A CC2D1A DYSF	1.66e-04	1105	50	8	35748872
Pubmed	Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes.	TFDP3 POGZ MGA	1.69e-04	74	50	3	29795351
Pubmed	Molecular characterization of the mouse superior lateral parabrachial nucleus through expression of the transcription factor Runx1.	LMX1B RUNX1	1.82e-04	14	50	2	21085653
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	KMT2C NCOA6	1.82e-04	14	50	2	12482968
Pubmed	TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.	TFDP3 TRIM24	1.82e-04	14	50	2	11331592
Pubmed	The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.	TRIM33 USP9X	1.82e-04	14	50	2	27626314
Interaction	SP7 interactions	TET2 TRIM33 KMT2C NCOA6 IGF2BP1 ARNT CHD7 POGZ TRIM24 MGA	3.17e-09	304	50	10	int:SP7
Interaction	EGR2 interactions	TET2 TRIM33 KMT2C NCOA6 CHD7 POGZ TRIM24 MGA	9.04e-09	171	50	8	int:EGR2
Interaction	ASF1A interactions	SOX6 TRIM33 NCOA6 ARNT NELFA CHD7 POGZ TRIM24 MGA	9.36e-09	249	50	9	int:ASF1A
Interaction	CRX interactions	MED15 TET2 TRIM33 KMT2C ARNT CHD7 POGZ TRIM24 MGA	1.11e-08	254	50	9	int:CRX
Interaction	XRCC6 interactions	GTF2A1 NCOA6 EXOSC10 IGF2BP1 ARNT TOX4 FN1 TINF2 DYRK1A CHD7 RUNX1 DYSF TRIM24 MGA	3.48e-08	928	50	14	int:XRCC6
Interaction	ERG interactions	SOX6 TET2 TRIM33 KMT2C NCOA6 USP9X CHD7 TRIM24	7.14e-08	223	50	8	int:ERG
Interaction	AR interactions	MED15 TET2 TRIM33 KMT2C NCOA6 EXOSC10 ARNT FN1 NELFA MED12L CHD7 RUNX1 TRIM24 MGA	7.97e-08	992	50	14	int:AR
Interaction	DUXB interactions	TRIM33 CHD7 POGZ TRIM24	1.00e-07	18	50	4	int:DUXB
Interaction	CEBPA interactions	MED15 TET2 TRIM33 KMT2C NCOA6 EXOSC10 IGF2BP1 ARNT NELFA SRM CC2D1A CHD7 POGZ RUNX1 TRIM24	1.94e-07	1245	50	15	int:CEBPA
Interaction	NANOG interactions	TRIM33 KMT2C EXOSC10 IGF2BP1 ARNT USP9X CHD7 POGZ TRIM24 MGA	2.39e-07	481	50	10	int:NANOG
Interaction	YAP1 interactions	MED15 KMT2C NCOA6 EXOSC10 ARNT TOX4 USP9X CC2D1A WWTR1 POGZ RUNX1 MGA NFAT5 DCP1A	2.68e-07	1095	50	14	int:YAP1
Interaction	HNF4A interactions	TRIM33 KMT2C NCOA6 ARNT CHD7 POGZ TRIM24 MGA	3.55e-07	275	50	8	int:HNF4A
Interaction	HNF1B interactions	SOX6 TET2 KMT2C CHD7 POGZ TRIM24 MGA	4.20e-07	190	50	7	int:HNF1B
Interaction	FEV interactions	KMT2C NCOA6 ARNT CHD7 POGZ TRIM24 MGA	6.57e-07	203	50	7	int:FEV
Interaction	CNOT3 interactions	MED15 TOB2 DYRK1A R3HDM2 RUNX1 TRIM24 DCP1A	7.49e-07	207	50	7	int:CNOT3
Interaction	CNOT1 interactions	GTF2A1 TOB2 FN1 DYRK1A R3HDM2 WWTR1 TRIM24 DCP1A	7.76e-07	305	50	8	int:CNOT1
Interaction	FOS interactions	TRIM33 KMT2C NCOA6 ARNT RUNX1 TRIM24 MGA NFAT5	9.21e-07	312	50	8	int:FOS
Interaction	SOX2 interactions	SOX6 TET2 TRIM33 KMT2C NCOA6 EXOSC10 IGF2BP1 ARNT FN1 USP9X CHD7 POGZ SLFN5 RUNX1 TRIM24	1.06e-06	1422	50	15	int:SOX2
Interaction	SOX7 interactions	TET2 TRIM33 KMT2C CHD7 TRIM24	1.81e-06	82	50	5	int:SOX7
Interaction	LHX4 interactions	TRIM33 KMT2C CHD7 POGZ TRIM24 MGA	3.36e-06	166	50	6	int:LHX4
Interaction	SOX17 interactions	TRIM33 KMT2C NCOA6 CHD7 TRIM24	3.75e-06	95	50	5	int:SOX17
Interaction	TUT4 interactions	IGF2BP1 OTUD4 R3HDM2 TRIM24 DCP1A	3.75e-06	95	50	5	int:TUT4
Interaction	SMAD2 interactions	MED15 TRIM33 KMT2C NCOA6 USP9X DYRK1A WWTR1 RUNX1	4.39e-06	385	50	8	int:SMAD2
Interaction	CIC interactions	SOX6 ARNT LMX1B DYRK1A OTUD4 CHD7 POGZ RUNX1 MGA NFAT5	4.95e-06	673	50	10	int:CIC
Interaction	LHX1 interactions	KMT2C CHD7 POGZ TRIM24 MGA	5.58e-06	103	50	5	int:LHX1
Interaction	PABPC1 interactions	TET2 TRIM33 KMT2C TOB2 IGF2BP1 FN1 OTUD4 R3HDM2 RUNX1 DCP1A	6.91e-06	699	50	10	int:PABPC1
Interaction	TERF2IP interactions	TRIM33 NCOA6 ARNT TINF2 NELFA CHD7 POGZ TRIM24 MGA	7.49e-06	552	50	9	int:TERF2IP
Interaction	KLF5 interactions	TET2 KMT2C NCOA6 WWTR1 TRIM24 MGA	8.47e-06	195	50	6	int:KLF5
Interaction	NUP35 interactions	MED15 TRIM33 KMT2C NCOA6 ARNT DYRK1A WWTR1 TRIM24	8.90e-06	424	50	8	int:NUP35
Interaction	ELF4 interactions	TRIM33 POGZ RUNX1 TRIM24 MGA	9.57e-06	115	50	5	int:ELF4
Interaction	TBXT interactions	KMT2C NCOA6 CHD7 POGZ TRIM24	9.98e-06	116	50	5	int:TBXT
Interaction	SMG7 interactions	NCOA6 ARNT OTUD4 R3HDM2 WWTR1 TRIM24 DCP1A	1.30e-05	319	50	7	int:SMG7
Interaction	CREBBP interactions	TRIM33 NCOA6 ARNT DYRK1A WWTR1 TACC2 RUNX1 TRIM24 MGA	1.44e-05	599	50	9	int:CREBBP
Interaction	AGO2 interactions	NCOA6 IGF2BP1 NELFA OTUD4 R3HDM2 WWTR1 TRIM24 DCP1A	1.93e-05	472	50	8	int:AGO2
Interaction	FERMT3 interactions	EXOSC10 FN1 TINF2 RUNX1	2.43e-05	68	50	4	int:FERMT3
Interaction	NCOA2 interactions	SOX6 NCOA6 ARNT CC2D1A WWTR1	2.57e-05	141	50	5	int:NCOA2
Interaction	NCOA6 interactions	MED15 KMT2C GTF2A1 NCOA6 WWTR1	2.94e-05	145	50	5	int:NCOA6
Interaction	SMAD1 interactions	MED15 TET2 NCOA6 USP9X RUNX1 MGA	2.95e-05	243	50	6	int:SMAD1
Interaction	EYA4 interactions	MED15 TET2 GTF2A1 ARNT SOBP R3HDM2	2.95e-05	243	50	6	int:EYA4
Interaction	NCOR1 interactions	SOX6 TRIM33 IGF2BP1 ARNT WWTR1 RUNX1 MGA	2.98e-05	363	50	7	int:NCOR1
Interaction	CPEB1 interactions	IGF2BP1 OTUD4 CC2D1A R3HDM2 DCP1A	3.04e-05	146	50	5	int:CPEB1
Interaction	ELF5 interactions	TRIM33 KMT2C IGF2BP1 CHD7 TRIM24	3.14e-05	147	50	5	int:ELF5
Interaction	XRN1 interactions	EXOSC10 DYRK1A OTUD4 R3HDM2 WWTR1 DCP1A	4.12e-05	258	50	6	int:XRN1
Interaction	SOX6 interactions	SOX6 IGF2BP1 ARNT SOBP CHD7	4.30e-05	157	50	5	int:SOX6
Interaction	ASH2L interactions	KMT2C NCOA6 WWTR1 CHD7 RUNX1 MGA	4.78e-05	265	50	6	int:ASH2L
Interaction	SOX5 interactions	SOX6 IGF2BP1 CHD7 POGZ TRIM24	4.99e-05	162	50	5	int:SOX5
Interaction	LSM12 interactions	IGF2BP1 FN1 OTUD4 R3HDM2 DCP1A	5.29e-05	164	50	5	int:LSM12
Interaction	PAX2 interactions	KMT2C CHD7 POGZ MGA	5.85e-05	85	50	4	int:PAX2
Interaction	PHC1 interactions	TET2 FN1 RUNX1 MGA	6.13e-05	86	50	4	int:PHC1
Interaction	TNRC6A interactions	KMT2C NCOA6 OTUD4 R3HDM2 TRIM24 DCP1A	6.49e-05	280	50	6	int:TNRC6A
Interaction	TEAD1 interactions	KMT2C ARNT WWTR1 CHD7 MGA	7.40e-05	176	50	5	int:TEAD1
Interaction	SLX4 interactions	TRIM33 EXOSC10 TOX4 NELFA DYRK1A POGZ TRIM24 MGA	7.53e-05	572	50	8	int:SLX4
Interaction	WWTR1 interactions	NCOA6 EXOSC10 ARNT TOX4 WWTR1 POGZ RUNX1	7.71e-05	422	50	7	int:WWTR1
Interaction	KLF15 interactions	MED15 KMT2C IGF2BP1 POGZ TRIM24 MGA	7.87e-05	290	50	6	int:KLF15
Interaction	TLX3 interactions	TET2 KMT2C NCOA6 CHD7 POGZ TRIM24	8.02e-05	291	50	6	int:TLX3
Interaction	PML interactions	MED15 TET2 TRIM33 ARNT NELFA TACC2 SLFN5 RUNX1 TRIM24 DCP1A	8.18e-05	933	50	10	int:PML
Interaction	HCFC1 interactions	MED15 KMT2C NCOA6 WWTR1 RUNX1 MGA	8.33e-05	293	50	6	int:HCFC1
Interaction	ZFP36 interactions	IGF2BP1 DYRK1A OTUD4 R3HDM2 DCP1A	8.44e-05	181	50	5	int:ZFP36
Interaction	POU5F1 interactions	TRIM33 EXOSC10 TOX4 USP9X CHD7 TRIM24 MGA RFX2	8.70e-05	584	50	8	int:POU5F1
Interaction	LHX2 interactions	KMT2C CHD7 POGZ TRIM24 MGA	8.89e-05	183	50	5	int:LHX2
Interaction	LHX3 interactions	KMT2C CHD7 POGZ TRIM24 MGA	9.36e-05	185	50	5	int:LHX3
Interaction	LATS1 interactions	TET2 IGF2BP1 USP9X OTUD4 WWTR1 MGA DCP1A	1.00e-04	440	50	7	int:LATS1
Interaction	SMAD3 interactions	MED15 TRIM33 NCOA6 USP9X DYRK1A RUNX1 TRIM24	1.10e-04	447	50	7	int:SMAD3
Interaction	MYOD1 interactions	TRIM33 KMT2C RUNX1 TRIM24 MGA	1.17e-04	194	50	5	int:MYOD1
Interaction	PEX5 interactions	TRIM33 TINF2 USP9X CAPRIN2 TRIM24	1.20e-04	195	50	5	int:PEX5
Interaction	KMT2A interactions	MED15 KMT2C NCOA6 WWTR1 RUNX1 DNAH8	1.22e-04	314	50	6	int:KMT2A
Interaction	GATA2 interactions	KMT2C NCOA6 CHD7 RUNX1 TRIM24	1.32e-04	199	50	5	int:GATA2
Interaction	ZEB1 interactions	GTF2A1 IGF2BP1 ARNT WWTR1 MGA	1.35e-04	200	50	5	int:ZEB1
Interaction	LSM8 interactions	EXOSC10 ARNT MGA DCP1A	1.43e-04	107	50	4	int:LSM8
Interaction	TAF7 interactions	GTF2A1 WWTR1 TRIM24 MGA	1.49e-04	108	50	4	int:TAF7
Interaction	MED1 interactions	MED15 TET2 NCOA6 MED12L RUNX1	1.55e-04	206	50	5	int:MED1
Interaction	SEC24C interactions	MED15 IGF2BP1 FN1 USP9X DYRK1A	1.59e-04	207	50	5	int:SEC24C
Interaction	NFIC interactions	SOX6 TET2 POGZ TRIM24 MGA	1.70e-04	210	50	5	int:NFIC
Interaction	DDX3X interactions	TET2 TRIM33 IGF2BP1 FN1 USP9X OTUD4 LRRC7 RUNX1	1.84e-04	651	50	8	int:DDX3X
Interaction	MEX3B interactions	IGF2BP1 OTUD4 CC2D1A R3HDM2 DCP1A	2.19e-04	222	50	5	int:MEX3B
Interaction	CLTA interactions	TET2 IGF2BP1 FN1 DYRK1A CC2D1A DCP1A	2.23e-04	351	50	6	int:CLTA
Interaction	IGF2BP1 interactions	SOX6 IGF2BP1 FN1 OTUD4 R3HDM2 RUNX1 TRIM24	2.42e-04	508	50	7	int:IGF2BP1
Interaction	NFIX interactions	SOX6 KMT2C POGZ TRIM24 MGA	2.43e-04	227	50	5	int:NFIX
Interaction	ELF1 interactions	POGZ RUNX1 TRIM24 MGA	2.69e-04	126	50	4	int:ELF1
Interaction	VDR interactions	NCOA6 OTUD4 RUNX1 TRIM24	2.77e-04	127	50	4	int:VDR
Interaction	LPP interactions	TINF2 DYRK1A WWTR1 DCP1A	2.77e-04	127	50	4	int:LPP
Interaction	PAX6 interactions	KMT2C NCOA6 CHD7 POGZ TRIM24 MGA	2.79e-04	366	50	6	int:PAX6
Interaction	FLNC interactions	FN1 DYRK1A SRM OTUD4 DYSF	2.80e-04	234	50	5	int:FLNC
Interaction	RSPH1 interactions	TRIM33 FN1 USP9X POGZ	3.12e-04	131	50	4	int:RSPH1
Interaction	TLE3 interactions	SOX6 MED15 TET2 ARNT OTUD4 RUNX1	3.22e-04	376	50	6	int:TLE3
Interaction	WBP2NL interactions	OTUD4 MGA	3.27e-04	11	50	2	int:WBP2NL
Interaction	H3C1 interactions	TRIM33 KMT2C EXOSC10 DYRK1A CHD7 POGZ TRIM24 MGA DNAH8	3.29e-04	901	50	9	int:H3C1
Interaction	CDC16 interactions	TRIM33 WWTR1 RUNX1 TRIM24 MGA	3.52e-04	246	50	5	int:CDC16
Interaction	PRRC2A interactions	SOX6 IGF2BP1 OTUD4 R3HDM2 WWTR1 RUNX1	3.86e-04	389	50	6	int:PRRC2A
Interaction	SOBP interactions	SOX6 SOBP	3.92e-04	12	50	2	int:SOBP
Interaction	LHX6 interactions	TRIM33 LMX1B OTUD4	4.03e-04	58	50	3	int:LHX6
Interaction	CREB1 interactions	GTF2A1 ARNT TOX4 DYRK1A POGZ	4.08e-04	254	50	5	int:CREB1
Interaction	PRMT1 interactions	TET2 EXOSC10 IGF2BP1 FN1 USP9X OTUD4 RUNX1 MGA DCP1A	4.12e-04	929	50	9	int:PRMT1
Interaction	RB1 interactions	NCOA6 ARNT DYRK1A TFDP3 WWTR1 MGA	4.13e-04	394	50	6	int:RB1
Interaction	PCMT1 interactions	TET2 NCOA6 FN1 DYRK1A WWTR1	4.23e-04	256	50	5	int:PCMT1
Interaction	HELZ interactions	IGF2BP1 OTUD4 R3HDM2 TRIM24 DCP1A	4.30e-04	257	50	5	int:HELZ
Interaction	ASCL2 interactions	KMT2C NCOA6	4.62e-04	13	50	2	int:ASCL2
Interaction	C10orf71 interactions	DYRK1A TRIM24	4.62e-04	13	50	2	int:C10orf71
Interaction	RNF31 interactions	TET2 TRIM33 IGF2BP1 OTUD4 MGA DNAH8	4.65e-04	403	50	6	int:RNF31
Interaction	ALKBH3 interactions	USP9X OTUD4 MGA	4.67e-04	61	50	3	int:ALKBH3
GeneFamily	PHD finger proteins	TRIM33 KMT2C TRIM24	5.84e-04	90	33	3	88
GeneFamily	Cyclins\|Mediator complex	MED15 MED12L	1.65e-03	33	33	2	1061
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM33 TRIM24	1.30e-02	95	33	2	59
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 TRIM33 KMT2C USP9X MED12L CHD7 NFAT5	4.99e-08	180	50	7	M8239
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	GTF2A1 SOBP USP9X CAPRIN2 WWTR1 CHD7 RUNX1 TRIM24 NFAT5	6.74e-05	803	48	9	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	USP9X MED12L OTUD4 NFAT5 DCP1A	8.90e-05	201	48	5	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000	SOX6 TRIM33 GTF2A1 SOBP USP9X WWTR1 CHD7 RUNX1 TRIM24	9.26e-05	837	48	9	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000	USP9X MED12L OTUD4 NFAT5 DCP1A	9.32e-05	203	48	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500	USP9X OTUD4 NFAT5 DCP1A	1.37e-04	116	48	4	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	SOX6 IGF2BP1 SOBP R3HDM2 NFAT5	2.08e-06	186	50	5	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SOX6 IGF2BP1 SOBP R3HDM2 NFAT5	2.08e-06	186	50	5	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Influenza_Severe-B_intermediate\|Influenza_Severe / Disease group and Cell class	MED12L CHD7 ODC1 DNAH8	4.33e-05	174	50	4	4276bdaac53aebd3084323a90ecde572d3177446
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 MED12L CHD7 RUNX1	4.43e-05	175	50	4	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TET2 TOX4 USP9X RFX2	5.16e-05	182	50	4	dc32f8f6a3b13918eb8e93c018f5823d86344080
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FN1 SOBP TACC2 RUNX1	5.16e-05	182	50	4	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	KMT2C USP9X SLFN5 NFAT5	5.27e-05	183	50	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	saliva-Severe-critical_progression_d28-40\|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)	TET2 NCOA6 TOX4 DYSF	5.61e-05	186	50	4	0095560ca776b01aa473ad4d6015ed78fc93ff51
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KMT2C USP9X DYRK1A NFAT5	5.85e-05	188	50	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	droplet-Limb_Muscle-nan-3m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYRK1A CC2D1A POGZ DCP1A	5.97e-05	189	50	4	16a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	SOX6 IGF2BP1 SOBP TRIM24	6.48e-05	193	50	4	503a979328c68b096680b71359a26f02fafdff35
ToppCell	PCW_07-8.5\|World / Celltypes from embryonic and fetal-stage human lung	SOX6 IGF2BP1 TACC2 CHD7	6.61e-05	194	50	4	5759c83308df017f1faae248e9b85388e25254f0
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 USP9X ODC1 RUNX1	7.01e-05	197	50	4	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate\|Influenza_Severe / Disease, condition lineage and cell class	MED12L CHD7 ODC1 DNAH8	7.15e-05	198	50	4	ab622fee61714471af3a7be0af356e8a484dcaff
ToppCell	mild-B_memory\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SOBP CHD7 ODC1 DNAH8	7.29e-05	199	50	4	025bb65629d9e20c374e8f1ba08c36d1bb569190
Drug	geldanamycin	TET2 GTF2A1 TOB2 FN1 RTTN OTUD4 SLFN5 NFAT5	1.16e-06	371	49	8	ctd:C001277
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	TRIM33 DYRK1A TACC2 CHD7 TRIM24 MGA	2.53e-06	182	49	6	3887_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; HL60; HT_HG-U133A	MED15 GTF2A1 FN1 TFDP3 WWTR1 RUNX1	3.87e-06	196	49	6	3049_DN
Drug	x ap	NCOA6 SRM ODC1	5.14e-06	16	49	3	CID000065020
Drug	MGBB	SRM ODC1	2.71e-05	4	49	2	CID009576807
Drug	ZK 119010	FN1 ODC1	2.71e-05	4	49	2	CID000130936
Drug	N-cyclohexyl-1,3-propanediamine	SRM ODC1	2.71e-05	4	49	2	CID000018718
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	TRIM33 DYRK1A TACC2 TRIM24 MGA	3.29e-05	171	49	5	7535_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	TRIM33 DYRK1A TACC2 RUNX1 TRIM24	4.20e-05	180	49	5	4541_DN
Drug	AC1NBNXJ	SRM ODC1	4.52e-05	5	49	2	CID004470983
Drug	2,2-difluoroputrescine	SRM ODC1	4.52e-05	5	49	2	CID000124237
Drug	pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A	GTF2A1 TOB2 FN1 SOBP RUNX1	4.79e-05	185	49	5	7528_UP
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	TRIM33 TOB2 TACC2 POGZ MGA	5.04e-05	187	49	5	7080_DN
Drug	norspermine	DYRK1A SRM ODC1	5.35e-05	34	49	3	CID000078350
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A	MED15 NOD1 CC2D1A RUNX1 NFAT5	5.71e-05	192	49	5	2081_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	MED15 TRIM33 TINF2 SOBP NFAT5	6.00e-05	194	49	5	1060_UP
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; MCF7; HT_HG-U133A	GTF2A1 ARNT NOD1 DYSF NFAT5	6.00e-05	194	49	5	6878_UP
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A	ARNT TOX4 NOD1 OTUD4 POGZ	6.00e-05	194	49	5	5049_DN
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MED15 TRIM33 NOD1 POGZ DYSF	6.30e-05	196	49	5	5020_DN
Drug	probucol; Up 200; 10uM; MCF7; HG-U133A	NOD1 CC2D1A RUNX1 MGA DCP1A	6.30e-05	196	49	5	592_UP
Drug	prednisolone; Down 200; 1uM; MCF7; HG-U133A	TRIM33 GTF2A1 DYRK1A POGZ RUNX1	6.30e-05	196	49	5	265_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A	TRIM33 ARNT FN1 WWTR1 DYSF	6.45e-05	197	49	5	3039_DN
Drug	(+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A	TOB2 FN1 TINF2 WWTR1 TRIM24	6.45e-05	197	49	5	161_DN
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; HL60; HT_HG-U133A	TOB2 TFDP3 RUNX1 NFAT5 RFX2	6.45e-05	197	49	5	2488_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	ARNT TINF2 CAPRIN2 OTUD4 NFAT5	6.61e-05	198	49	5	7003_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A	ARNT CC2D1A WWTR1 RUNX1 NFAT5	6.61e-05	198	49	5	2458_DN
Drug	Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A	GTF2A1 ARNT TINF2 CC2D1A RUNX1	6.61e-05	198	49	5	4185_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A	GTF2A1 FN1 WWTR1 NFAT5 RFX2	6.77e-05	199	49	5	4334_UP
Drug	n-butyl-1,3-diaminopropane	SRM ODC1	6.77e-05	6	49	2	CID000095733
Drug	ethyl stearate	SRM ODC1	6.77e-05	6	49	2	CID000008122
Drug	M2 t	SRM ODC1	6.77e-05	6	49	2	CID000167321
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	TINF2 WWTR1 POGZ RUNX1 NFAT5	6.93e-05	200	49	5	2075_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	AMELY FN1 RUNX1 DYSF RFX2	6.93e-05	200	49	5	5570_UP
Drug	saran	DYRK1A RUNX1 NFAT5	7.49e-05	38	49	3	CID000062706
Drug	mg BC	SRM ODC1	9.46e-05	7	49	2	CID009589355
Drug	MGBCP	SRM ODC1	1.26e-04	8	49	2	CID009576877
Drug	N-carbamoylputrescine	SRM ODC1	1.26e-04	8	49	2	CID000000502
Drug	CP-65	FN1 ODC1	1.26e-04	8	49	2	CID000452628
Drug	AdoDATO	SRM ODC1	1.62e-04	9	49	2	CID000100766
Drug	5'-methylthiotubercidin	SRM ODC1	1.62e-04	9	49	2	CID000188350
Drug	NSC401575	NELFA ODC1 RUNX1 NFAT5	1.71e-04	129	49	4	CID000003165
Disease	Neurodevelopmental Disorders	KMT2C LMX1B DYRK1A POGZ	1.76e-05	93	49	4	C1535926
Disease	vital capacity	SOX6 TET2 NCOA6 FN1 LMX1B CAPRIN2 OTUD4 CHD7 TRIM24 NFAT5	2.97e-05	1236	49	10	EFO_0004312
Disease	mean reticulocyte volume	SOX6 TRIM33 TOB2 NOD1 RTTN DYRK1A OTUD4 RUNX1	4.71e-05	799	49	8	EFO_0010701
Disease	serum albumin measurement	SOX6 EXOSC10 ARNT SNX8 R3HDM2 RUNX1 DYSF	5.22e-05	592	49	7	EFO_0004535
Disease	esophagus squamous cell carcinoma (is_implicated_in)	TET2 KMT2C RUNX1	5.81e-05	45	49	3	DOID:3748 (is_implicated_in)
Disease	disorder of pharynx	TET2 ARNT DYSF	6.21e-05	46	49	3	MONDO_0020592
Disease	tea consumption measurement	SOX6 TOB2 ARNT NFAT5	6.34e-05	129	49	4	EFO_0010091
Disease	C-reactive protein measurement	SOX6 NCOA6 TOB2 IGF2BP1 LMX1B DYRK1A R3HDM2 CHD7 NFAT5	1.45e-04	1206	49	9	EFO_0004458
Disease	Colorectal Carcinoma	TET2 KMT2C ARNT FN1 SNX8 ODC1 DNAH8	1.51e-04	702	49	7	C0009402
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	RUNX1 MGA	1.76e-04	12	49	2	C0023485
Disease	mean platelet volume	TET2 TOX4 RTTN SNX8 DYRK1A CHD7 RUNX1 RFX2	2.54e-04	1020	49	8	EFO_0004584
Disease	coronary artery disease	SOX6 TET2 NCOA6 IGF2BP1 FN1 R3HDM2 LRRC7 NFAT5	7.23e-04	1194	49	8	EFO_0001645
Disease	airway responsiveness measurement	SOBP CAPRIN2	7.28e-04	24	49	2	EFO_0006897
Disease	Glioblastoma Multiforme	TRIM33 FN1 RUNX1	8.42e-04	111	49	3	C1621958
Disease	myeloid white cell count	TET2 GTF2A1 FN1 MED12L DYRK1A R3HDM2 CHD7	8.55e-04	937	49	7	EFO_0007988
Disease	Intellectual Disability	KMT2C RTTN MED12L POGZ ODC1	8.60e-04	447	49	5	C3714756
Disease	FEV/FEC ratio	MED15 TET2 TRIM33 LMX1B OTUD4 R3HDM2 WWTR1 MGA	8.68e-04	1228	49	8	EFO_0004713
Disease	Sezary Syndrome	TET2 KMT2C	9.23e-04	27	49	2	C0036920
Disease	Hematopoetic Myelodysplasia	TET2 RUNX1	1.07e-03	29	49	2	C2713368
Disease	intellectual disability (is_implicated_in)	DYRK1A CC2D1A	1.14e-03	30	49	2	DOID:1059 (is_implicated_in)
Disease	puberty onset measurement	SOX6 NCOA6 NFAT5	1.19e-03	125	49	3	EFO_0005677
Disease	macrophage inflammatory protein 1a measurement	RTTN CAPRIN2	1.30e-03	32	49	2	EFO_0008218
Disease	Focal glomerulosclerosis	FN1 LMX1B	1.64e-03	36	49	2	C0017668

Protein segments in the cluster

Peptide	Gene	Start	Entry
PRQQQQQTELDMVPG	ARNT	501	P27540
QQPRVRQQALMPVPG	AMELY	106	Q99218
QIQQPLTNQVMPDIV	DYRK1A	61	Q13627
QSMQQNQDPEVFVQP	DCP1A	461	Q9NPI6
ENPVNPMGQQMPIDQ	CHD7	31	Q9P2D1
SDSQNVVQPPFQQPM	R3HDM2	616	Q9Y2K5
PFQGFIENPVMRQNI	OTUD4	866	Q01804
ALQPQPEQQPFSQML	KIAA0895L	56	Q68EN5
PVLMPNQDPFLQAAQ	KMT2C	2241	Q8NEZ4
QPTFPMVPQQLQHQQ	KMT2C	3301	Q8NEZ4
QDPMRPRQPQVRQQQ	MED12L	2046	Q86YW9
GLQAMQPQQPLFPRQ	MED12L	2091	Q86YW9
PVAMVAPQTQAPAQQ	NELFA	411	Q9H3P2
NTQPNLQPVMFRNPG	MGA	1821	Q8IWI9
DQQIQDMPVPQNDPQ	LRRC7	511	Q96NW7
QAPEQEMVQVFIPAQ	IGF2BP1	401	Q9NZI8
MVPNIPPQEASNRLQ	DNAH8	1221	Q96JB1
PMVVQQPPVQPQVQQ	MED15	351	Q96RN5
PRVQVESFNQVQAMP	NOD1	636	Q9Y239
QMDPVAQPQVNPTLQ	GPR152	351	Q8TDT2
IQTPMLSQEQAQPPQ	NFAT5	1191	O94916
RNPMVQQGNVPPNFM	NCOA6	476	Q14686
NPVPPLVRQQINEMH	EXOSC10	556	Q01780
RQAQQMVQPQSPVAV	FN1	31	P02751
PVPPEVAQQYQDIMQ	CC2D1A	871	Q6P1N0
DNPPVQQIVQLSPVM	GOLGA6C	676	A6NDK9
QAMQTVFNVNAPLPP	CAPRIN2	761	Q6IMN6
PPQREANIYMVPQNI	DYSF	1311	O75923
LMQQFQNPDFPPEVE	ODC1	416	P11926
PQSQMQDTRQIQPSP	RUNX1	236	Q01196
PQDKSNFQQMEVPPR	RTTN	146	Q86VV8
NFQQMEVPPRPVVNQ	RTTN	151	Q86VV8
DPNLSQPIMPIQQNV	USP9X	2261	Q93008
QAAPQMLQQQPPRLI	TRIM33	556	Q9UPN9
PQAIVQQVPAPSRMQ	SNX8	41	Q9Y5X2
MQPISLPRVQQVPQQ	RFX2	46	P48378
PVRNVRPVQNAMNQV	POGZ	156	Q7Z3K3
MRQFFTVGQQPQIPI	SOX6	721	P35712
SVVLQQQVIPQMQPG	GTF2A1	181	P52655
QPQMPKQNPVVEQNS	TRIM24	431	O15164
PIFMEQQIMQQIRPP	SOBP	396	A7XYQ1
QQIMQQIRPPFIRGP	SOBP	401	A7XYQ1
LAEPMEQNPPQQQRL	TINF2	211	Q9BSI4
QEGRQQPVPAPQQKM	TACC2	1086	O95359
EPVQPLTQQQVAQMQ	SRM	261	P19623
VNIDQQVVIGMPQRP	TFDP3	51	Q5H9I0
QQGRFVPPDMMQPQQ	YIPF5	46	Q969M3
MRNMIPQDNENPPQQ	ZNF788P	1	Q6ZQV5
RLSGPVMQQSQQPQP	TET2	1516	Q6N021
QQPPQQPRMARSPTN	TOB2	211	Q14106
MNPAPQLQDEIQPQL	UBQLN3	491	Q9H347
YLQQVMQEARQNPPP	SLFN5	721	Q08AF3
MPQPPTQQQVTILQQ	TOX4	451	O94842
TPMNINPQQTRFPDF	WWTR1	346	Q9GZV5
PLAPPQQQIVAMEQS	LMX1B	311	O60663